The Medicines Company Newswire

Comprehensive Real-Time News Feed for The Medicines Company.

Results 1 - 20 of 107 in The Medicines Company

  1. Single shot antibiotic approved for skin infectionsRead the original story

    Monday Aug 11 | Chemistry World

    Intravenous antibiotic Orbactiv oritavancin , from US firm The Medicines Company , has been approved by the US Food and Drug Administration .

    Comment?

  2. The Medicines Co. Offers Investors 25% UpsideRead the original story w/Photo

    Thursday Aug 7 | Barron's

    Late Wednesday, the Food and Drug Administration approved its new treatment for acute skin infections called Orbactiv, one of several experimental drugs Medicines Co. (ticker: MDCO) is counting on to help offset the sales it will lose when its top-selling drug Angiomax faces generic...

    Comment?

  3. FDA Approves Orbactiv (Oritavancin) for Skin InfectionsRead the original story

    Thursday Aug 7 | P&T Community

    The FDA has approved Orbactiv (oritavancin, The Medicines Company) for injection for the treatment of adults with acute bacterial skin and skin-structure infections (ABSSSIs) caused by susceptible designated Gram-positive bacteria, including ...

    Comment?

  4. FDA Approves Orbactiv, First One-Dose Treatment For Staph Infections And MSRARead the original story w/Photo

    Thursday Aug 7 | Medical Daily

    Antibiotics become ineffective when bacteria either develop a resistance to them or patients fail to finish a course.

    Comment?

  5. FDA Approves ORBACTIV for Skin Structure InfectionsRead the original story

    Thursday Aug 7 | Surgical Products

    The Medicines Company today announced that the U.S. Food and Drug Administration has approved ORBACTIVa for injection for the treatment of adults with acute bacterial skin and skin structure infections caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus .

    Comment?

  6. Oritavancin Approved for One-Dose Treatment of Skin InfectionsRead the original story

    Thursday Aug 7 | ASHP

    ... formation of abscesses on the skin and in the soft tissue of arms and legs. Orbactiv is marketed by The Medicines Company in cartons containing three 400-mg vials that are to be stored at 20-25 C. Company vice president Michael McGuire announced ...

    Comment?

  7. The Medicines Co. could have 25% upside, Barron's saysRead the original story

    Wednesday Aug 6 | Theflyonthewall.com

    ... should bolster its earnings, the paper adds. Reference Link The Medicines Co. Orbactiv approved by FDA The Medicines Company announced that the FDA has approved Orbactiv for injection for the treatment of adults with acute bacterial skin and skin ...

    Comment?

  8. FDA Approves ORBACTIV for Skin Stucture InfectionsRead the original story

    Thursday Aug 7 | Surgical Products

    The Medicines Company today announced that the U.S. Food and Drug Administration has approved ORBACTIVa for injection for the treatment of adults with acute bacterial skin and skin structure infections caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus .

    Comment?

  9. Orbactiv Approved to Treat Skin InfectionsRead the original story w/Photo

    Thursday Aug 7 | Kansas City InfoZine

    ... ation tests and interaction with warfarin, a drug used to prevent blood clots. Orbactiv is marketed by The Medicines Company, based in Parsippany, N.J.

    Comment?

  10. The Medicines Company and Alnylam Pharmaceuticals to Host RNAi...Read the original story

    Thursday Aug 7 | Freshnews

    The Medicines Company today announced that in collaboration with Alnylam Pharmaceuticals it will be hosting the "ALN-PCSsc for the treatment of Hypercholesterolemia" RNAi Roundtable webcast on August 14, 2014.

    Comment?

  11. FDA Approves ORBACTIVa for Acute Bacterial Skin and Skin Structure InfectionsRead the original story w/Photo

    Thursday Aug 7 | Pharmaceutical Processing

    The Medicines Company today announced that the U.S. Food and Drug Administration has approved ORBACTIVa for injection for the treatment of adults with acute bacterial skin and skin structure infections caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus .

    Comment?

  12. FDA Approves The Medicines Company's ORBACTIVa (oritavancin) for Use...Read the original story

    Wednesday Aug 6 | Customer Interaction Solutions

    The Medicines Company today announced that the U.S. Food and Drug Administration has approved ORBACTIV for injection for the treatment of adults with acute bacterial skin and skin structure infections caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus .

    Comment?

  13. FDA Approves The Medicines Company's Acute Skin Infection Drug OrbactivRead the original story

    Wednesday Aug 6 | BioSpace

    ... tests and interaction with warfarin, a drug used to prevent blood clots. Orbactiv is marketed by The Medicines Company, based in Parsippany, N.J. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health ...

    Comment?

  14. Are You Properly Selecting Your CMO Partners?Read the original story w/Photo

    Monday Aug 4 | BioResearch Online

    ... met Angie Green at the 2013 WTG Global Pharma Manufacturing Summit in Boston. She had recently left The Medicines Company as head of commercial outsourced manufacturing. Angie gave a presentation on the steps sponsors should follow when selecting ...

    Comment?

  15. Are You Properly Selecting Your CMO Partners?Read the original story w/Photo

    Monday Aug 4 | Pharmaceutical Online

    ... met Angie Green at the 2013 WTG Global Pharma Manufacturing Summit in Boston. She had recently left The Medicines Company as head of commercial outsourced manufacturing. Angie gave a presentation on the steps sponsors should follow when selecting ...

    Comment?

  16. The Medicines Company to Host Infectious Disease Care Investor and...Read the original story

    Monday Aug 4 | Customer Interaction Solutions

    The Medicines Company has scheduled an Infectious Disease Care Investor and Analyst meeting for Wednesday, September 24, 2014 from 8:30 am to 12:00 noon.

    Comment?

  17. AcelRx stock plunges after FDA rejects pain drug deviceRead the original story

    Monday Jul 28 | Reuters

    ... Livnat said, maintaining his "market outperform" rating on the stock. The delay bodes well for the The Medicines Company whose rival experimental pain product Ionsys will now likely gain a timing advantage. The company submitted an application to ...

    Comment?

  18. The Medicines Company Reports Second Quarter and First Half 2014 ResultsRead the original story

    Wednesday Jul 23 | Business Wire

    The Medicines Company , a global company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/intensive care hospitals, today announced second quarter and first half results for 2014.

    Comment?

  19. The Medicines Company (MDCO) Scheduled to Post Earnings on WednesdayRead the original story

    Monday Jul 21 | AmericanBankingNews.com

    The Medicines Company is scheduled to be releasing its Q214 earnings data on Wednesday, July 23rd.

    Comment?

  20. 3 Stocks With Jaw-Dropping Growth PotentialRead the original story

    Jul 18, 2014 | The Motley Fool

    ... At the end of the day, MiMedx is gaining ground in an exciting space, making it a stock to watch. The Medicines Company is well positioned for growth The Medicines Company sports a diversified product pipeline headlined by Angiomax, a potent ...

    Comment?